Haematology 2018
Maintenance therapy in DLBCL
Enzastaurin
Everolimus
Rituximab
DFS 0.92 (0.69–1.22)
OS 0.75 (0.51–1.10)
Crump et al. JCO 2016
Jaeger et al. Haematologica 2015
Witzig et al. ASCO 2016
Made with FlippingBook - professional solution for displaying marketing and sales documents online